Mustang Bio, Inc. (NASDAQ:MBIO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael S. Weiss Other companies: Checkpoint Therapeutics Inc (Director · Since at least Sep 9, 2016); Fortress Biotech, Inc. (Executive Vice Chairman, Strategic Development · Since at least Jan 1, 2016); TG Therapeutics, Inc. (Chairman, President, and Chief Executive Officer · Since at least Dec 31, 2015); Avenue Therapeutics, Inc. (Director · Mar 13, 2017 – Aug 7, 2018 · Past); National Holdings Corporation (Director · Sep 12, 2016 – Sep 12, 2016 · Past) | Chairman of the Board of Directors · Since at least Sep 26, 2016 |
| Lindsay A. Rosenwald Other companies: Avenue Therapeutics, Inc. (Director · Since at least Sep 23, 2024); Checkpoint Therapeutics Inc (Director · Since at least May 14, 2024); Journey Medical Corporation (Chairman · Since at least Mar 22, 2024); Fortress Biotech, Inc. (Chairman, President and Chief Executive Officer · Since at least Nov 14, 2023) | Director · Since at least Nov 5, 2026 |
| Neil Herskowitz Other companies: Journey Medical Corporation (Director · Since at least Nov 16, 2021); Checkpoint Therapeutics Inc (Director · Since at least Jun 14, 2018); Avenue Therapeutics, Inc. (Director · Since at least Oct 9, 2017); National Holdings Corporation (Director · Feb 12, 2018 – Feb 12, 2018 · Past) | Director · Since at least Jun 14, 2018 |
| David Jin Other companies: Avenue Therapeutics, Inc. (Interim Chief Financial Officer and Chief Operating Officer · Since at least Nov 5, 2026); Fortress Biotech, Inc. (Chief Financial Officer and Head of Corporate Development · Since at least Apr 1, 2026) | Director · Since at least Nov 5, 2026 |
| James B Murphy Other companies: Decibel Therapeutics Inc (See Remarks · Oct 7, 2022 – Oct 7, 2022 · Past) | Interim CFO · Jan 19, 2024 – Jan 19, 2024 · Past |
| Adam J. Chill | Director · Since at least Dec 30, 2025 |
| Greg Furrow | Chief Quality Officer · Since at least Nov 4, 2026 |
| Manuel Litchman | President, Chief Executive Officer and Director · Since at least Apr 24, 2017 |
| Michael J. Zelefsky | Director · Since at least Jul 29, 2022 |